Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Growth100Percnt

C.SHRC

Explaination of Earnings from Investopedia

BREAKING DOWN Earnings Earnings are the amount of profit that a company...

March 31, 2019

V.CVM.H

Barchart

Barchart is showing CVR as a strong buy with a continuing uptrend outlook.

March 30, 2019

V.CVM.H

RE:RE:CATALYST-Undervalued-Under the Radar-Disruptive/GameChanger

wounded-  Yes its my personal view :) But in my opinion its a very...

March 30, 2019

V.CVM.H

CATALYST-Undervalued-Under the Radar-Disruptive/GameChanger

That should be enough of a catalyst for most investors. Oh ya...FDA approval...

March 29, 2019

V.CVM.H

.32

Are we going to push past .32 to finish off the week?

March 29, 2019

V.CVM.H

RE:RE:RE:warrants

No worries. In the big scheme of things that pp won't make a whole lot of...

March 28, 2019

V.CVM.H

RE:Not so fast Growth !

gamer- I understand.  It shouldn't be a problem to fill. ...

March 27, 2019

C.SHRC

RE:Recurring themes

I'm not sure how much time the CFO spends at Sharc. As far as I'm...

March 26, 2019

C.SHRC

RE:RE:RE:RE:RE:SHARC announces $5 Million Private Placement

If the phone is constantly ringing off the hook at the Sharc office we should...

March 26, 2019

C.SHRC

RE:RE:RE:RE:SHARC announces $5 Million Private Placement

Its pretty sad to see the market cap of this global company at $10M when it...

March 26, 2019

C.SHRC

RE:RE:RE:SHARC announces $5 Million Private Placement

Hermano I have no idea but by the end of Q2 if there is no revenue increase...

March 26, 2019

V.CVM.H

RE:RE:warrants

Good job wounded.

March 26, 2019

C.SHRC

RE:SHARC announces $5 Million Private Placement

HGBlog- We shareholders are sure hoping to see some revenue coming in since...

March 26, 2019

V.CVM.H

RE:Not so fast Growth !

The news release doesn't say who is actually providing the service of the...

March 25, 2019

V.CVM.H

Time to Push Past .40

Ok people there is a huge investment opportunity here! Its time to push this...

March 25, 2019

V.CVM.H

RE:RE:The Cannacord.............slam !

You need money to make money. At the current share structure this could be a ...

March 25, 2019

V.CVM.H

RE:RE:RE:RE:PP Mar 21/19

The dollar amount of the previous pp was much lower than what CVR was wanting...

March 25, 2019

V.CVM.H

Nov 21st/2017 Interview w/Peter Bakema

http://www.kereport.com/2017/11/21/cvr-medial-device-measure-stenosed...

March 24, 2019

V.CVM.H

March 20th/2018 Interview with Tony Robbins

http://www.kereport.com/2018/03/20/cvr-medical-timelines-additional-trials...

March 24, 2019

V.CVM.H

Uptrend?

Could this be the start of an uptrend?

March 24, 2019

Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next

Featured Company

Diagnostear Technologies Inc

Diagnostear Technologies Inc C.DTR

DiagnosTear is a leading ophthalmic company developing and commercializing disruptive diagnostic solutions for better ... view more »